SpringWorks Therapeutics, Inc. (SWTX)
USD 36.0
(-4.56%)
USD 36.0
(-4.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.44 Million | 6.14 Million | - | 35 Million | - | - |
| Cost of Revenue | 422 Thousand | 1.89 Million | 490 Thousand | 349 Thousand | 192 Thousand | 17.32 Thousand |
| Gross Profit | 5.02 Million | 4.25 Million | -490 Thousand | 34.65 Million | -192 Thousand | -17.32 Thousand |
| Operating Expenses | 348.03 Million | 280.67 Million | 173.46 Million | 81.32 Million | 59.23 Million | 18.49 Million |
| Selling, General and Administrative Expenses | 197.55 Million | 134.55 Million | 71.79 Million | 29.46 Million | 16.69 Million | 8.59 Million |
| Research and Development Expenses | 150.48 Million | 146.12 Million | 101.67 Million | 51.85 Million | 42.54 Million | 9.89 Million |
| Other Expenses | - | -138 Thousand | -152 Thousand | 25 Thousand | - | - |
| Cost and Expenses | 348.46 Million | 280.67 Million | 173.46 Million | 81.32 Million | 59.23 Million | 18.49 Million |
| Operating Income | -343.01 Million | -280.67 Million | -173.46 Million | -46.32 Million | -59.23 Million | -18.49 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -3.25 Million | -698 Thousand | -1.33 Million | -3.54 Million | 678 Thousand |
| Earnings before Tax | -325.1 Million | -277.41 Million | -173.91 Million | -45.57 Million | -58.3 Million | -17.81 Million |
| Net Income | -325.1 Million | -274.16 Million | -173.21 Million | -44.24 Million | -54.75 Million | -17.81 Million |
| Earnings Per Share Basic | -5.15 | -5.14 | -3.57 | -1.02 | -1.27 | -0.80 |
| Earnings Per Share Diluted | -5.15 | -5.14 | -3.57 | -1.02 | -1.27 | -0.80 |
| Weighted Average Shares Outstanding | 63.12 Million | 53.29 Million | 48.49 Million | 43.3 Million | 43 Million | 22.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.12 Million | 53.29 Million | 48.49 Million | 43.3 Million | 43 Million | 22.19 Million |
| Gross Margin | 0.92 | 0.69 | - | 0.99 | - | - |
| EBIT Margin | -62.67 | -45.66 | - | -1.31 | - | - |
| Profit Margin | -59.68 | -44.60 | - | -1.26 | - | - |
| EBITDA | -341.34 Million | -280.67 Million | -172.97 Million | -45.97 Million | -59.04 Million | -18.47 Million |
| Earnings Before Tax Margin | -62.97 | -45.66 | - | -1.32 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 59.73 Million | 21 Million | 5.44 Million | 5.44 Million | 5.58 Million | 5.82 Million |
| Cost of Revenue | 3.29 Million | 1.93 Million | 422 Thousand | 960 Thousand | 933 Thousand | 833 Thousand |
| Gross Profit | 56.43 Million | 19.07 Million | 5.02 Million | 4.48 Million | 4.65 Million | 4.99 Million |
| Operating Expenses | 101.35 Million | 113 Million | 348.03 Million | 103.48 Million | 83.99 Million | 82.85 Million |
| Selling, General and Administrative Expenses | 56.99 Million | 59.38 Million | - | 59.83 Million | 46.54 Million | 46.99 Million |
| Research and Development Expenses | 44.36 Million | 53.62 Million | - | 43.65 Million | 37.45 Million | 35.85 Million |
| Other Expenses | - | - | - | 373 Thousand | -76 Thousand | -98 Thousand |
| Cost and Expenses | 104.65 Million | 114.93 Million | 348.46 Million | 103.91 Million | 83.99 Million | 82.85 Million |
| Operating Income | -44.92 Million | -93.93 Million | -343.01 Million | -98.46 Million | -83.99 Million | -82.85 Million |
| Interest Expense | - | - | - | 4.27 Million | - | - |
| Income Tax Expense | - | 685.72 Thousand | -22.94 Million | -5.6 Million | -5.66 Million | -382 Thousand |
| Earnings before Tax | -39.91 Million | -87.38 Million | -325.1 Million | -94.32 Million | -79.43 Million | -77.92 Million |
| Net Income | -39.91 Million | -87.38 Million | -325.1 Million | -94.32 Million | -79.43 Million | -77.92 Million |
| Earnings Per Share Basic | -0.54 | -1.18 | - | -1.28 | -1.27 | -1.25 |
| Earnings Per Share Diluted | -0.54 | -1.18 | - | -1.28 | -1.27 | -1.25 |
| Weighted Average Shares Outstanding | 74.12 Million | 73.76 Million | 63.12 Million | 73.48 Million | 62.52 Million | 62.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.12 Million | 73.76 Million | 63.12 Million | 73.48 Million | 62.52 Million | 62.46 Million |
| Gross Margin | 0.94 | 0.91 | 0.92 | 0.82 | 0.83 | 0.86 |
| EBIT Margin | -0.74 | -4.44 | - | -17.98 | -14.95 | -14.22 |
| Profit Margin | -0.67 | -4.16 | -59.68 | -17.32 | -14.22 | -13.37 |
| EBITDA | -44.07 Million | -93.2 Million | - | -97.92 Million | -83.5 Million | -82.85 Million |
| Earnings Before Tax Margin | -0.75 | -4.47 | -62.97 | -18.08 | -15.04 | -14.22 |
GUS
300875
JET
4045
PHAR
603589